ライフサイエンスコーパス: in vitro fertilization

1 he efficiency of blastocyst production after in vitro fertilization.

2 c-Myc), this line can only be maintained by in vitro fertilization.

3 ients were induced in the aged oocytes after in vitro fertilization.

4 were within the range observed with standard in vitro fertilization.

5 7BL/6J and C57BL/6N, with the routine use of in vitro fertilization.

6 xpected in a noncancer population undergoing in vitro fertilization.

7 ty therapy, possibly decreasing the need for in vitro fertilization.

8 otes are considered an unwanted byproduct of in vitro fertilization.

9 tural pregnancy and pregnancy conceived from in vitro fertilization.

10 187, and elicited a concomitant reduction of in vitro fertilization.

11 evelop may improve the success and safety of in vitro fertilization.

12 inase A phosphorylation, sperm motility, and in vitro fertilization.

13 ion success of embryos transferred following in vitro fertilization.

14 plantation bovine embryos (n = 23) following in vitro fertilization.

15 te cleavage and blastocyst development after in-vitro fertilization.

16 companies in the United States do not cover in vitro fertilization, a few states mandate such covera

17 Antibodies to CD9 and CD98 inhibited in vitro fertilization and binding of the ADAM 3 disinte

18 After in vitro fertilization and culture, 76% of the blastocys

19 otropins, and some oocytes are competent for in vitro fertilization and early embryogenesis.

20 After in vitro fertilization and embryo transfer, healthy prog

21 Back-cross animals were generated using in vitro fertilization and genome scans performed utiliz

22 The use of in vitro fertilization and intracytoplasmic sperm inject

23 ART procedures such as in vitro fertilization and intracytoplasmic sperm inject

24 ditions as well as survival of embryos after in vitro fertilization and of organs after transplantati

25 study teases apart these mechanisms by using in vitro fertilization and shows that susceptibility of

26 chemotherapy, she harvested her eggs through in vitro fertilization and subsequently used preimplanta

27 ntracytoplasmic sperm injection coupled with in-vitro fertilization, as well as refinements in micros

28 lo3(-/-) sperm exhibit some fertility within in vitro fertilization assays.

29 epsis associated with chorioamnionitis in an in vitro fertilization-assisted pregnancy.

30 on failure occurring in approximately 50% of in vitro fertilization attempts.

31 iated with Huntington's disease can, through in vitro fertilization, avoid passing it on to one's off

32 c sperm injection (ICSI) is a technique that in vitro fertilization clinics use to treat a myriad of

33 we were therefore able to conduct controlled in vitro fertilization competitions while concurrently m

34 nsistent for two experimental repeats of the in vitro fertilization competitions.

35 ed after 13 embryo transfers (31% versus 53% in vitro fertilization controls).

36 ICSI was performed in a programmed in vitro fertilization cycle using fresh spermatozoa.

37 at required complete coverage performed more in vitro fertilization cycles than clinics in states tha

38 By screening day-3 embryos during in vitro fertilization cycles, we identified an associat

39 is measured in human follicular fluid during in vitro fertilization cycles.

40 d embryonic stem cells (nt-ESCs), as well as in vitro fertilization embryo-derived ESCs (IVF-ESCs).

41 infertile women of a similar age undergoing in vitro fertilization-embryo transfer (45.0 v 38.2; P =

42 During in vitro fertilization, embryos deemed clinically useles

43 Although in vitro fertilization experiments suggest that the maiz

44 In addition, in vitro fertilization, F2 inheritance and cross-fosteri

45 ciated with a decreased risk of abortion and in vitro fertilization failure.

46 uploid, leading to spontaneous miscarriages, in vitro fertilization failures and, when viable, severe

47 ive associations between ALPP polymorphisms, in vitro fertilization failures, and miscarriages.

48 ho underwent dilation subsequently underwent in vitro fertilization for embryo transfer (IVF-ET) or i

49 sted in more than one child, couples without in-vitro fertilization insurance coverage and couples wi

50 ly conceived fetuses and fetuses produced by in vitro fertilization, intracytoplasmic sperm injection

51 ng preimplantation culture, embryo transfer, in vitro fertilization, intracytoplasmic sperm injection

52 The corresponding odds ratios with in vitro fertilization (IVF) (165 birth defects, 7.2%) w

53 erved human embryos that were created during in vitro fertilization (IVF) and are in excess of clinic

54 ation of gene knockout NRG mice by combining in vitro fertilization (IVF) and CRISPR/Cas9 technology.

55 uman infertility have been overcome by using in vitro fertilization (IVF) and embryo transfer (ET) te

56 eggs following parthenogenetic activation or in vitro fertilization (IVF) and tracked their developme

57 Male-female couples who underwent in vitro fertilization (IVF) and/or intrauterine insemin

58 ormally at 2-cell mouse embryos generated by in vitro fertilization (IVF) but not SCNT.

59 C-based preimplantation genomic screening in in vitro fertilization (IVF) enables accurate and cost-e

60 and spontaneous abortion in women undergoing in vitro fertilization (IVF) from 1994 to 2003.

61 e national multiple birth rates, and data on in vitro fertilization (IVF) from 1997 through 2011 were

62 The prevalence of oocyte donation for in vitro fertilization (IVF) has increased in the United

63 rofiles in E18.5 mouse concepti generated by in vitro fertilization (IVF) in two different genetic ba

64 ase in estrogen levels, safety of performing in vitro fertilization (IVF) in women with breast cancer

65 in vitro fertilization (IVF) is one of the most highly p

66 In vitro fertilization (IVF) is the most widely used tec

67 lihood of achieving a live birth with repeat in vitro fertilization (IVF) is unclear, yet treatment i

68 maximize birth rates, physicians who perform in vitro fertilization (IVF) often transfer multiple emb

69 e recourse to assisted reproduction, usually in vitro fertilization (IVF) or donor insemination (DI),

70 eproductive therapy (ART) couples treated by in vitro fertilization (IVF) or intracytoplasmic sperm i

71 iation of urinary phthalate metabolites with in vitro fertilization (IVF) outcomes, accounting for mu

72 ver the allele encoding arginine (R72) among in vitro fertilization (IVF) patients.

73 preimplantation genetic diagnosis (PGD) and in vitro fertilization (IVF) performed for the preventio

74 ly transduced mouse spermatozoa were used in in vitro fertilization (IVF) studies, and when followed

75 rom the mated female uterus partially rescue in vitro fertilization (IVF) that failed with epididymal

76 gnosis (PGD) to select an embryo produced by in vitro fertilization (IVF) that was unaffected by FA a

77 on (ICSI) was initially developed as part of in vitro fertilization (IVF) to treat male-factor infert

78 ntrations of PFR metabolites and outcomes of in vitro fertilization (IVF) treatment among couples rec

79 Outcomes of in vitro fertilization (IVF) treatment are traditionally

80 Previous studies of breast cancer risk after in vitro fertilization (IVF) treatment were inconclusive

81 Nearly 75% of in vitro fertilization (IVF) treatments do not result in

82 roximately 5 million infants were born after in vitro fertilization (IVF) treatments.

83 standing infertility who is about to undergo in vitro fertilization (IVF) using donor oocytes from an

84 sented 13 days after an oocyte retrieval for in vitro fertilization (IVF) with a positive home pregna

85 When semen was used for in vitro fertilization (IVF), 10% of embryos were transg

86 Before 8 h of in vitro fertilization (IVF), a mechanism exists that in

87 In in vitro fertilization (IVF), progesterone is often adde

88 of intracytoplasmic sperm injection (ICSI), in vitro fertilization (IVF), sperm removal, reinjection

89 uality in animal models and women undergoing in vitro fertilization (IVF), we consider it an ovarian

90 By examining a large set of zygotes from in vitro fertilization (IVF), we find that success in pr

91 oplasmic sperm injection (ICSI) and standard in vitro fertilization (IVF), we found that Ca(2+) influ

92 chromosome mosaicism observed in studies of in vitro fertilization (IVF)-derived human preimplantati

93 comes, is increasingly related to the use of in vitro fertilization (IVF).

94 n eggs and preimplantation embryos following in vitro fertilization (IVF).

95 nd obese infertile women who were undergoing in vitro fertilization (IVF).

96 lear evidence of a benefit over conventional in vitro fertilization (IVF).

97 implantation failure among women undergoing in vitro fertilization (IVF).

98 o the woman of human embryos created through in vitro fertilization (IVF).

99 ne allele is enriched in patients undergoing in vitro fertilization (IVF).

100 ted or related to their child as a result of in vitro fertilization (IVF).

101 ulture that markedly improved the outcome of in vitro fertilization (IVF).

102 ess beyond the two pronuclei stage following in vitro fertilization (IVF).

103 s from mother to child is now a reality with in vitro fertilization mitochondrial replacement techniq

104 These were produced by in vitro fertilization of Bos taurus taurus oocytes with

105 inhibits the binding of sperm to eggs during in vitro fertilization of ZP-free eggs.

106 y and 1,008 whose conception was assisted by in vitro fertilization or intrauterine insemination and

107 njected, blocks second polar body formation, in vitro fertilization, or cytokinesis.

108 cing through characterization of in vivo and in vitro fertilization phenotypes, including insights fr

109 s a clinical indicator of male fertility and in vitro fertilization potential: chromosome aneuploidy

110 In vitro fertilization-related and other experiments rev

111 Transgenic boar fertility was confirmed by in vitro fertilization, resulting in transgenic blastocy

112 reproductive outcomes among women undergoing in vitro fertilization: results from the EARTH study.

113 ata to determine utilization and outcomes of in vitro fertilization services according to the status

114 State-mandated insurance coverage for in vitro fertilization services is associated with incre

115 Of the states in which in vitro fertilization services were available, 3 states

116 ted in recombinant fertilin beta-EC prior to in vitro fertilization show reduced levels of sperm bind

117 option-at-birth study), and the Cardiff IVF (In Vitro Fertilization) Study (an adoption-at-conception

118 This suggests that research on improving in vitro fertilization success rates should move from it

119 at interest--particularly with the advent of in vitro fertilization techniques for treating male infe

120 ill be amenable to development of successful in vitro fertilization techniques.

121 ration in women with subfertility undergoing in vitro fertilization therapy.

122 o trigger egg maturation in women undergoing in vitro fertilization therapy.

123 uce ovarian stimulation for both in vivo and in vitro fertilization therapy.

124 t established method and the success rate of in-vitro fertilization using frozen-thawed embryos now a

125 omeres removed from 8-cell embryos following in vitro fertilization was analyzed for HLA genes simult

126 In vitro fertilization was compromised, especially at ea

127 In vitro fertilization was performed using ASMKO(+/-) oo

128 The extent of in vitro fertilization was reduced in a dose-dependent m

129 Using in vitro fertilization, we have rescued and characterize

130 d fertilization from 107 patients undergoing in vitro fertilization were analyzed by FISH using X-, 1

131 ones on muscle function, patients undergoing in vitro fertilization were tested during two phases of

132 M can potentially become a valuable tool for in vitro fertilization, where contrast agents and fluoro

133 of both recmSLLP1 and antibodies to SLLP1 on in vitro fertilization with both cumulus intact and zona

134 In vitro fertilization, with a cycle defined as an episo

135 y assisted reproductive technologies such as in vitro fertilization, yet pregnancy success rates usin